Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Bitcoin Treasury Exposure Goes Mainstream As Coinbase Soars On Joining The S&P 500

% of readers think this story is Fact. Add your two cents.


Bitcoin Treasury Exposure Goes Mainstream As Coinbase Soars On Joining The S&P 500

On May 19, 2025, Coinbase will officially join the S&P 500 – widely regarded as the most trusted, most tracked equity index in the world. With over $5 trillion in assets benchmarked to it, the S&P 500 isn’t just a measure of corporate strength – it’s a gravitational center of global capital allocation.

And starting next week, it will include Bitcoin treasury company.

Coinbase currently holds 9,267 BTC on its balance sheet, valued at $963.8 million at today’s price of $104,000 per Bitcoin, making it the 9th largest public corporate Bitcoin holder globally.

As Nick Ward reports for BitcoinMagazine.com, this marks a quiet turning point for Bitcoin in capital markets – one that reframes the treasury conversation and reshapes how companies think about index eligibility, institutional flows, and balance sheet strategy.

The Most Passive Flows in Finance Just Found Bitcoin

Coinbase’s addition to the index means something profound: millions of investors will soon have indirect exposure to Bitcoin—and they didn’t choose it.

Because the S&P 500 is tracked by passive strategies, funds and institutions must purchase Coinbase stock in proportion to its index weight. If Coinbase is assigned even a 0.20% weighting, that implies more than $10 billion in net inflows from index-tracking vehicles.

This is not speculative capital. This is mandatory exposure—capital governed by rules, not conviction.

And for the first time, those rules lead directly to Bitcoin.

Bitcoin Treasuries Are Now Index-Eligible

For years, Bitcoin on the corporate balance sheet was treated as a novelty—or worse, a liability. But Coinbase’s inclusion signals something different: Bitcoin exposure is now compatible with the highest standards of institutional eligibility.

It’s a powerful validation for public companies already holding Bitcoin—and a strategic consideration for those that aren’t. Index inclusion is not reserved for fiat-only treasuries. Coinbase’s addition confirms that sound operations and a Bitcoin-aligned balance sheet are not mutually exclusive.

In fact, they may now be complementary.

Strategy May Be Next to Join The S&P 500

Coinbase may be the first S&P 500 company with a Bitcoin treasury—but it likely won’t be the last.

Strategy ($MSTR), formerly MicroStrategy, is widely viewed as the next potential candidate. The company meets many of the S&P 500’s baseline criteria:

  • It is U.S.-based and publicly listed on the Nasdaq.

  • It has sufficient free float and market capitalization.

  • Its last four quarters of GAAP earnings are positive.

And perhaps most notably: Strategy is the largest corporate Bitcoin holder in the world—by far.

As of today, it holds 568,840 BTC, currently worth $59.16 billion.

Its balance sheet is no longer just Bitcoin-heavy – it is Bitcoin-native. If admitted, Strategy would represent an even deeper exposure to Bitcoin inside the world’s most influential index.

This matters. Because it signals that Bitcoin is becoming a foundational component of corporate capital formation—not an outlier.

From Signal to Strategy: A New Corporate Playbook

Coinbase’s entry – and Strategy’s potential follow-on – reinforces an emerging thesis: a Bitcoin treasury can enhance a company’s capital profile—not detract from it.

Here’s why:

  • Visibility: Index inclusion provides perpetual exposure to new capital.

  • Flows: Passive funds are forced buyers—providing liquidity and price support.

  • Perception: Bitcoin is no longer a reputational liability—it’s becoming a marker of long-term vision and resilience.

In this context, treasury strategy becomes a capital markets strategy. Holding Bitcoin isn’t just about hedging inflation or diversifying reserves—it’s about aligning your company with where capital is flowing.

BFC Perspective: The Bridge Has Been Crossed

From a Bitcoin For Corporations standpoint, this is not just news—it’s a case study in what institutional acceptance looks like.

Coinbase has:

  • Navigated the public markets as a Bitcoin-native company,

  • Maintained a material Bitcoin treasury position, and

  • Demonstrated that such positioning is not a barrier to index inclusion—it can be a feature.

And Strategy, with its commanding treasury and growing influence, may soon follow—cementing Bitcoin’s place at the core of U.S. corporate indices.

This should embolden public companies and pre-IPO candidates alike. It’s proof that Bitcoin alignment doesn’t isolate you from the traditional system—it can embed you deeper into it.

This is the BFC thesis in action: Bitcoin-native capital structures are compatible with institutional legitimacy.

What Comes Next: Bitcoin Is Entering the Core Portfolio

With Coinbase’s S&P 500 inclusion and Strategy potentially next, the implications are clear:

  • Bitcoin is no longer confined to speculative portfolios.

  • Bitcoin treasuries are now appearing in default asset allocations.

  • The passive indexing era is now passively onboarding Bitcoin—whether the end investor realizes it or not.

For CFOs and capital allocators, the takeaway is simple: Bitcoin on the balance sheet is no longer a bet – it’s a bridge. To the index. To the allocators. To the long game.

With Coinbase joining the S&P 500, Bitcoin exposure is entering the core of institutional portfolios—not through a financial product, but via a public company’s balance sheet. As Strategy positions to follow, this marks a broader shift: Bitcoin treasury strategy is becoming part of the mainstream capital structure.

Tyler Durden Tue, 05/13/2025 – 15:45


Source: https://freedombunker.com/2025/05/13/bitcoin-treasury-exposure-goes-mainstream-as-coinbase-soars-on-joining-the-sp-500/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.